ATE212228T1 - Eine nukleinsäure enthaltende homöopatische lösung - Google Patents

Eine nukleinsäure enthaltende homöopatische lösung

Info

Publication number
ATE212228T1
ATE212228T1 AT94402845T AT94402845T ATE212228T1 AT E212228 T1 ATE212228 T1 AT E212228T1 AT 94402845 T AT94402845 T AT 94402845T AT 94402845 T AT94402845 T AT 94402845T AT E212228 T1 ATE212228 T1 AT E212228T1
Authority
AT
Austria
Prior art keywords
polynucleotide
nucleic acid
homeopatical
soln
rna
Prior art date
Application number
AT94402845T
Other languages
English (en)
Inventor
Bernard Marichal
Maurice Jenaer
Original Assignee
Labo Life
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labo Life filed Critical Labo Life
Application granted granted Critical
Publication of ATE212228T1 publication Critical patent/ATE212228T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT94402845T 1993-12-09 1994-12-09 Eine nukleinsäure enthaltende homöopatische lösung ATE212228T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9314796A FR2713487B1 (fr) 1993-12-09 1993-12-09 Solutions de type homéopathique contenant un acide nucléique utilisables notamment dans la prévention ou le traitement de maladies infectieuses ou de maladies impliquant le dysfonctionnement d'un gène.

Publications (1)

Publication Number Publication Date
ATE212228T1 true ATE212228T1 (de) 2002-02-15

Family

ID=9453752

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94402845T ATE212228T1 (de) 1993-12-09 1994-12-09 Eine nukleinsäure enthaltende homöopatische lösung

Country Status (8)

Country Link
EP (1) EP0670164B1 (de)
AT (1) ATE212228T1 (de)
AU (1) AU1245595A (de)
CA (1) CA2178100A1 (de)
DE (1) DE69429714T2 (de)
ES (1) ES2171441T3 (de)
FR (1) FR2713487B1 (de)
WO (1) WO1995015761A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
WO2003006478A1 (en) 2001-07-10 2003-01-23 Oligos Etc. Inc. Oligonucleotide-containing pharmacological compositions and their use
WO2008102368A1 (en) * 2007-02-21 2008-08-28 Rajesh Shah Medicinal formulation containing a combination of hiv type i and hiv type ii
CA2798132A1 (en) * 2010-05-14 2011-11-17 Deseret Biologicals, Inc. Formulations of diluted genetic material and methods for making same
WO2012129519A1 (en) 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
WO2017126987A1 (ru) * 2016-01-18 2017-07-27 Анатолий Викторович ЗАЗУЛЯ Эритроциты для направленного транспорта лекарственного средства

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2592790A1 (fr) * 1986-01-16 1987-07-17 Villano Guy Preparation cosmetique a action regeneratrice et antirides
FR2609897B1 (fr) * 1987-01-28 1991-06-28 Bruttmann Georges Nouvelles formes galeniques de gammaglobulines pour administration par voie per- et sub-linguale
FR2680687A1 (fr) * 1991-08-29 1993-03-05 Etienne Marie Christine Compositions pharmaceutiques homeopathiques utilisees pour la fabrication de medicaments destines au traitement des maladies causees par des erreurs metaboliques et au traitement des maladies virales.
FR2699820B3 (fr) * 1992-12-24 1995-03-10 Eric Pichot Traitement homéopathique préventif des dysmytoses (cancer, leucémie) et malformations ou mutations génétiques.

Also Published As

Publication number Publication date
WO1995015761A1 (fr) 1995-06-15
AU1245595A (en) 1995-06-27
DE69429714D1 (de) 2002-03-14
EP0670164A1 (de) 1995-09-06
FR2713487A1 (fr) 1995-06-16
DE69429714T2 (de) 2002-09-12
FR2713487B1 (fr) 1996-02-02
CA2178100A1 (fr) 1995-06-15
EP0670164B1 (de) 2002-01-23
ES2171441T3 (es) 2002-09-16

Similar Documents

Publication Publication Date Title
Bartel et al. Isolation of new ribozymes from a large pool of random sequences
Ahlquist et al. Near identity of 3′ RNA secondary structure in bromoviruses and cucumber mosaic virus
Weaver et al. Specific sequences in native DNA that arrest synthesis by DNA polymerase alpha.
Goodarzi et al. Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase
US7807817B2 (en) Enzymatic nucleic acid molecules
DE69627698T2 (de) Eine in kaskaden verlaufende vervielfältigungsreaktion von nukleinsäuren
DE69432838D1 (de) Gensonden und Verfahren zum Nachweis vom menschlichen Immunschwäche-Virus Typ 1
NO933136L (no) Bestemmelse av nukleinsyrer ved polymerasekstensjon av oligonukleotider ved anvendelse av terminatorblandinger
DK0721988T3 (da) Kimærisk oligonucleotid og dets anvendelse ved opnåelse af transkripter af en nucleinsyre
ATE394410T1 (de) Hochspezifische primer, amplifizierungsverfahren und kits
Yoshikawa et al. Nucleotide sequences at the termini of phi 29 DNA.
US5858731A (en) Oligonucleotide libraries useful for producing primers
Dean et al. Mechanism of strand passage by Escherichia coli topoisomerase I. The role of the required nick in catenation and knotting of duplex DNA.
DE60039772D1 (de) Verfahren zur amplifikation von signal-flankierend
DE69429714D1 (de) Eine Nukleinsäure enthaltende homöopatische Lösung
Sagher et al. Abasic sites from cytosine as termination signals for DNA synthesis
Gould et al. Studies on encapsidated viroid-like RNA IV. requirement for infectivity and specificity of two RNA components from velvet tobacco mottle virus
Ratmeyer et al. An ethidium analog that binds with high specificity to a base-bulged duplex from the TAR RNA region of the HIV-1 genome
US5663062A (en) Oligonucleotide libraries useful for producing primers
DE3567875D1 (en) Process for the dissolution of deoxyribonucleic acids in non-aqueous solvents and mixed non-aqueous/aqueous solvent systems, solutions thereby obtained and their use
Volckaert et al. Nucleotide sequence of simian virus 40 Hind H restriction fragment
Golub et al. Joints formed by RecA protein from oligonucleotides and duplex DNA block initiation and elongation of transcription
Hatta et al. Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides
WO1993025707A3 (es) Procedimientos de amplificacion de genoma y mezclas de oligonucleotidos iniciadores para la deteccion y la identificacion de secuencias genomicas relacionadas
Milanesi et al. In vivo and in vitro transcription of SPP1 DNA by host RNA polymerase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification